Friday, May 20, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Granules Receives Health Canada Nod For Arthritis Tablets

Granules receives Health Canada nod for arthritis tablets

By Telangana Today
Published: Published Date - 05:59 PM, Mon - 30 August 21
The drug will be manufactured at the Granules manufacturing facility located at Gagillapur, Hyderabad.

Hyderabad: Hyderabad-based Granules India said it received marketing approval from Health Canada for Acetaminophen Extended-Release Tablets OTC, 650mg for the treatment of arthritis pain.

The drug will be manufactured at the Granules manufacturing facility located at Gagillapur, Hyderabad. The product is a bioequivalent to the reference listed drug, Tylenol Extended Release 650 Tablets.

Priyanka Chigurupati, ED, Granules USA & Granules Pharmaceuticals, said, “We received the approval within eight months of filing. This is a step towards global expansion of our core molecules. The approval of Acetaminophen Extended-Release Tablets OTC, 650mg, a complex Bi-layer Extended Released based formulation, is a good addition to our portfolio. We will be launching the product in the Canada market soon.”

Granules now have a total of two ANDS (abbreviated new drug submissions) approvals from Health Canada.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

  • Follow Us :
  • Tags
  • acetaminophen
  • arthritis
  • Granules
  • Health Canada

Related News

  • Some arthritis may be caused by mosquito-borne viruses

  • Granules Q3 net profit dips 31%

  • Granules gets USFDA nod for antidepressant drug

  • Granules’ US arm concludes FDA Audit with three minor observations

  • Link between gut microbiota and chronic inflammatory diseases

  • Granules India appoints Dr KVS Ram Rao as CEO

Latest News

  • FreshToHome plans expansion in Telangana, Andhra Pradesh

    4 hours ago
  • Editorial: Fillip to federal spirit

    5 hours ago
  • Opinion: Grow more foods that feed the hungry

    6 hours ago
  • After KTR number plate, KCR number plate turns heads in London

    6 hours ago
  • IPL 2022: Rajasthan Royals beat CSK by five wickets to finish second

    6 hours ago
  • Become a pro in Pipes and Cisterns topic in arithmetics

    6 hours ago
  • 2,40,000 job vacancies available at DEET; grab one now!

    6 hours ago
  • IPL 2022 Preview: Delhi Capitals meet Mumbai Indians in virtual quarter-final

    6 hours ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam